In addition to the hypoxic microenvironment being clinically significant for GBM, vascularization is critical: GBM is one of the most highly vascularized tumors and expresses high levels of VEGF, which is therefore an attractive target for anti-angiogenic therapies [18]. The gene discussed is VEGFA; the disease is glioblastoma.